Applicant (Person in charge) |
Name: Matthew Bellgard | |
---|---|---|
Position: Chair | ||
Organization: APEC Rare Disease Network | ||
Country: Australia | ||
E-mail: apecrdn@gmailcom | ||
Topic | The APEC Rare Disease Network proposes a joint AHC-RDN Workshop on Accelerating Regulatory Convergence for Orphan Medical Products Topic areas could include but are not limited to: Regulatory definitions of RD, OMP, and unmet medical need; Pre-licensing support including scientific and regulatory advice; Expeditedaccelerated development, registration, and approval pathways, including reliance; Innovative clinical trial designs, methods, and ethics approvals for small patient populations; Use of real-world evidence in the review of OMPs and in post-authorization activities; Local clinical trial waivers and use of international clinical trial data for OMPs to address small populations; Exemptions of requirements for local manufacturing, sampling, import testing, and local GMP certificates; Tax credits andor fee waivers for development activities related to RDs and OMPs; and, Establishment of a specific and enforceable market exclusivity period for OMPs | |
Proposal Content (Describe your proposal, including potential areas of collaboration, purpose, and expected impact.) |
The Workshop aims to facilitate the identification and exchange of: 1 best practices for orphan medical product regulation among APEC regulatory authorities and industry; and 2 focus areas and mechanisms for cooperation in APEC to strengthen regulatory systems, build regulatory capacity, and accelerate regulatory convergence for the review and approval of orphan medical products | |
Expected date | 2022-08-17 to 2022-08-18 (Total 2 Days) | |
Expected Venue (Economy) | Thailand | |
Expected No. of Guests | 40 | Open |
Expected Total Cost of the Event | $40,000 | |
Attach File | No Attachment found. |